Tasly Pharmaceutical Group Co., Ltd (SHA:600535)

SHA:600535 Revenue

Tasly Pharmaceutical Group had revenue of 2.23B CNY in the quarter ending June 30, 2025, a decrease of -3.86%. This brings the company's revenue in the last twelve months to 8.41B, down -2.76% year-over-year. In the year 2024, Tasly Pharmaceutical Group had annual revenue of 8.50B, down -2.03%.

• Revenue (ttm): 8.41B
• Revenue Growth: -2.76%
• P/S Ratio: 2.89
• Revenue / Employee: 767.90K
• Employees: 10,958
• Market Cap: 24.28B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	8.50B	-175.87M	-2.03%
Dec 31, 2023	8.67B	36.58M	0.42%
Dec 31, 2022	8.64B	685.47M	8.62%
Dec 31, 2021	7.95B	-5.62B	-41.43%
Dec 31, 2020	13.58B	-5.42B	-28.54%